Seven More Products are Approved by US FDA

Two oral contraceptive products, two immediate-release products and three extended-release products, all NOVAST-developed, receive approval from the US FDA including Lo- Malmorede™, Estradiol and Norethindrone Acetate Tablets, Oxybutynin Chloride Tablets, Desmopressin Acetate Tablets, Clonidine Hydrochloride ER Tablets, Nifedipine ER Tablets and Diltiazem Hydrochloride ER Capsules.